SCHEDULE 13G: Altium Capital Management Discloses 9.99% Passive Stake in Sharps Technology Inc.
Ownership Disclosure
Altium Capital Management LLC and its affiliated entities have reported a passive 9.99% beneficial ownership stake in Sharps Technology Inc., totaling 549,294 shares of common stock.
Summary
- Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP, and Altium Healthcare Long Short GP LLC (collectively, 'Reporting Persons') have jointly filed a Schedule 13G.
- The filing indicates that the Reporting Persons beneficially own 549,294 shares of Sharps Technology Inc. Common Stock.
- This ownership represents 9.99% of the Issuer's outstanding Common Stock.
- The percentage is calculated based on 5,498,439 shares of Common Stock outstanding as of January 28, 2025, as reported in Sharps Technology Inc.'s Form 424B4 filed on January 29, 2025.
- The beneficial ownership includes 308,163 shares of Common Stock, 1,785,000 shares issuable upon conversion of Series A Warrants, and 1,785,000 shares issuable upon conversion of Series B Warrants, though the actual beneficial ownership is capped at 9.99% due to a 'Warrant Blocker'.
- The Reporting Persons certify that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer, consistent with a passive investment strategy.
Sentiment
Score: 6
Explanation: The disclosure of a significant passive stake by an institutional investor is generally a neutral to slightly positive signal, indicating investor interest without implying immediate strategic changes or financial distress.
Positives
- A significant institutional investor, Altium Capital Management, has taken a substantial 9.99% stake in Sharps Technology Inc., which can be viewed as a vote of confidence in the company.
- The passive nature of the investment (Schedule 13G filing) indicates that Altium is not seeking to influence or change control of the company, which may provide stability.
Future Outlook
The document does not contain any forward-looking statements or guidance from Sharps Technology Inc. management.
Industry Context
The involvement of 'Altium Healthcare' in the reporting entities suggests that Sharps Technology Inc. operates within the healthcare sector, aligning with specialized investment funds focused on this industry.
Stakeholder Impact
- Shareholders may view the entry of a new significant institutional investor as a positive signal, potentially increasing confidence in the company's stock.
- The passive nature of the investment suggests no immediate impact on corporate strategy or governance for employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of event which requires filing of this statement (ownership threshold reached). |
| 01/29/2025 | Date Sharps Technology Inc.'s Form 424B4 was filed, providing the basis for outstanding shares calculation. |
| 02/04/2025 | Date the Schedule 13G filing was signed by Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP, and Altium Healthcare Long Short GP LLC. |
Keywords
Sharps Technology Inc., Altium Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Passive Investment, Healthcare Technology, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.